Mingl Chang

Title: The Innovations of Mingl Chang

Introduction

Mingl Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on developing methods for treating inflammatory diseases and immune disorders.

Latest Patents

Mingl Chang holds a patent for "Alpha-enolase specific antibodies and method of use in immune diseases." This patent describes a method for treating inflammatory diseases or immune disorders by administering an antagonist against ENO1. The antagonist binds to ENO1 and inhibits its plasminogen receptor activity. This treatment may be applicable for various conditions, including multiple sclerosis, rheumatoid arthritis, Crohn's disease, ulcerative colitis, systemic lupus erythematosus, chronic obstructive pulmonary disease (COPD), asthma, allergies, psoriasis, type 1 diabetes mellitus, atherosclerosis, or osteoporosis. He has 1 patent to his name.

Career Highlights

Mingl Chang has worked at prominent institutions such as the Development Center for Biotechnology and the National Health Research Institutes. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Throughout his career, Mingl Chang has collaborated with esteemed colleagues, including Shih-Chong Tsai and Ta-Tung Yuan. These partnerships have fostered innovation and enhanced the impact of his work in the field of immunology.

Conclusion

Mingl Chang's contributions to the field of immunology through his patent and collaborations highlight his dedication to advancing medical science. His innovative approaches to treating immune disorders demonstrate the potential for significant advancements in healthcare.